Bosnia and Herzegovina vs Yemen: Deaths from Parkinson's disease
Bosnia and Herzegovina
357.06 deaths
in 2021
Yemen
353.52 deaths
in 2021
Bosnia and Herzegovina rank
77th
Yemen rank
78th
Deaths from Parkinson's disease over time
- Bosnia and Herzegovina
- Yemen
How they compare
Bosnia and Herzegovina currently reports 357.06 deaths against 353.52 deaths in Yemen, a difference of 3.54 deaths.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 77th and Yemen ranks 78th of 194 countries.
Across the 3 decades both report, Bosnia and Herzegovina averaged higher in 2 and Yemen in 1.
Head to head by decade
| Decade | Bosnia and Herzegovina | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 246.87 deaths | 218.87 deaths | 28.01 deaths | Bosnia and Herzegovina |
| 2010s | 312.27 deaths | 310.46 deaths | 1.82 deaths | Bosnia and Herzegovina |
| 2020s | 362.76 deaths | 366.35 deaths | 3.59 deaths | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Bosnia and Herzegovina or Yemen?
- Bosnia and Herzegovina, at 357.06 deaths against 353.52 deaths in Yemen as of 2021.
- What is the difference in deaths from parkinson's disease between Bosnia and Herzegovina and Yemen?
- 3.54 deaths, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Yemen?
- 22 years are reported by both, from 2000 to 2021.
- How do Bosnia and Herzegovina and Yemen rank globally for deaths from parkinson's disease?
- Bosnia and Herzegovina ranks 77th and Yemen ranks 78th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.